ZANARDELLI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 2.799
NA - Nord America 1.863
AS - Asia 173
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 1
Totale 4.840
Nazione #
PL - Polonia 2.228
US - Stati Uniti d'America 1.857
IT - Italia 178
IE - Irlanda 162
SE - Svezia 113
HK - Hong Kong 52
CN - Cina 51
FI - Finlandia 36
VN - Vietnam 34
GB - Regno Unito 24
DE - Germania 18
SG - Singapore 11
BE - Belgio 10
JO - Giordania 8
ES - Italia 7
UA - Ucraina 7
CA - Canada 6
CH - Svizzera 6
JP - Giappone 6
TR - Turchia 5
IN - India 4
NL - Olanda 3
RU - Federazione Russa 3
AU - Australia 2
FR - Francia 2
KR - Corea 2
RO - Romania 2
A1 - Anonimo 1
CO - Colombia 1
EU - Europa 1
Totale 4.840
Città #
Warsaw 2.228
Fairfield 299
Woodbridge 168
Dublin 162
Ashburn 159
Chandler 153
Seattle 125
Houston 119
Cambridge 113
Wilmington 105
Ann Arbor 84
Altamura 57
Lawrence 55
Princeton 55
Florence 54
Beijing 32
Medford 28
Dong Ket 26
Kent 25
Hong Kong 22
San Diego 22
Boston 20
Falls Church 16
Phoenix 16
Boardman 15
New York 15
Jacksonville 12
Shanghai 11
Brussels 10
Buffalo 10
Rome 9
Barcelona 7
Hillsboro 7
Norwalk 7
Bern 6
Singapore 6
Toronto 5
Cagliari 4
Andover 3
Bremen 3
Düsseldorf 3
Los Angeles 3
Moscow 3
Old Bridge 3
Arezzo 2
Castelliri 2
Chiaravalle Centrale 2
Genoa 2
Grevenbroich 2
Hangzhou 2
Hefei 2
Laurel 2
Livorno 2
Münster 2
Pune 2
Tappahannock 2
Venice 2
Anguillara Sabazia 1
Auburn Hills 1
Bentivoglio 1
Bogotá 1
Brooklyn 1
Broomfield 1
Camparada 1
Cantagallo 1
Chicago 1
Cockermouth 1
Creazzo 1
Dallas 1
Fiesole 1
Frankfurt Am Main 1
Genova 1
Gragnano 1
Guangzhou 1
Hanover 1
Irvine 1
Izmir 1
Kilburn 1
London 1
Modena 1
Monteroni D'arbia 1
Montréal 1
Naaldwijk 1
New Bedfont 1
Palo Alto 1
Paraggi 1
Pisa 1
Poggibonsi 1
Prescot 1
Redmond 1
Rotterdam 1
Saffron Walden 1
Salerno 1
San Mateo 1
San Polo 1
Seoul 1
Stevenage 1
Tivoli 1
Turin 1
Valera Fratta 1
Totale 4.354
Nome #
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 251
Role of Nitric Oxide, Nitric Oxide Synthase, Soluble Guanylyl Cyclase, and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development 244
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 240
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 237
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 233
Delay of morphine tolerance by palmitoylethanolamide 218
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 216
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 209
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 209
Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats 201
Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin 198
Pretreatment with relaxin does not restore no-mediated modulation of calcium signal in coronary endothelial cells isolated from spontaneously hypertensive rats 198
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 196
Low dose native type II collagen prevents pain in a rat osteoarthritis model 193
PPAR-γ Impairment Alters Peroxisome Functionality in Primary Astrocyte Cell Cultures 191
Oxaliplatin-neuropathy: a safe pharmacological approach based on the activation of different apoptotic pathways in normal vs tumoral cells 180
Palmitoylthanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-apha-mediated mechanism. 160
Peroxisome determination in optical microscopy: a useful tool derived by a simplification of an old ultrastructural technique. 90
Effects of the combination of β-hydroxy-β-methyl butyrate and R(+) lipoic acid in a cellular model of sarcopenia 88
Widespread pain reliever profile of a flower extract of Tanacetum parthenium 86
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1 85
Estratti di Astragalus membranaceus loro preparazione ed uso come antiperalgesici ed antiallodinici 83
Oxidative, Metabolic, And Apoptotic Responses of Schwann Cells to High Glucose Levels 71
In Vitro Evidence for the Use of Astragali Radix Extracts as Adjuvant against Oxaliplatin-Induced Neurotoxicity 68
Serotonergic modulation in neuropathy induced by oxaliplatin: Effect on the 5HT2C receptor 67
An in vivo sudy on oxaliplatin-induced neuropathic pain: the protective effects of antioxidant compounds 61
Nicotine is a pain reliever in trauma- and chemotherapy-induced neuropathy models 60
Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: Could it correlate with in vivo neuropathy? 54
Involvement of alpha7 nAChR downregulation in the rat oxaliplatin-induced neuropathy. 53
Glia activation along the nervous system during oxaliplatin-dependent neuropathic pain. 49
Chemotherapy-induced neuropathy: involvement of the alpha7 nAChR subtype. 48
Glia role in oxaliplatin-induced neuropathic pain. 47
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 46
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 43
Neuropathic pain: looking for a disease modifyng agent 42
alpha-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement. 40
Morphological features and glial activation in oxaliplatin-dependent neuropathic pain. 37
Involvement of alpha7 nAChR downregulation in rat oxaliplatin-induced neuropathy 34
Oxaliplain-induced neruopathic pain: glial involvement in spinal cord and brain. 33
Aminopyridine-3,5-dicarbonitriles as non-nucleoside adenosine A1 receptor agonists. 26
Involvement of alpha7 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation. 22
Totale 4.907
Categoria #
all - tutte 10.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019296 0 0 0 0 0 0 0 0 0 0 164 132
2019/20201.133 93 117 45 82 136 107 105 135 106 71 121 15
2020/2021778 65 88 34 97 57 72 49 56 57 139 25 39
2021/2022300 9 21 34 13 8 14 20 26 9 19 39 88
2022/2023704 80 156 31 42 44 129 94 35 68 1 17 7
2023/2024255 12 34 44 6 18 51 8 38 7 5 32 0
Totale 4.907